N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes release from human monocyte-derived macrophages in response to zymosan and human recombinant interferon-gamma. 1991

R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
Laboratoire de Chimie Biologique, Faculté de Pharmacie, Université Paris V, France.

Secretion of N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes by human blood monocyte-derived macrophages in response to zymosan and human recombinant interferon-gamma was studied. Macrophages were found to release NAG in response to zymosan, but interferon-gamma has no effect on secretion. Isoenzyme separation by isoelectric focusing demonstrates that non stimulated and zymosan or interferon-gamma treated macrophages release predominantly NAG B and, to a lesser extent, NAG A isoenzymes. In all these conditions, the intracellular intermediate form NAG I could not be detected in the media. Thus, activated macrophages may not be the source of NAG intermediate forms I and P in pathological or maternal serum. In contrast, macrophages could contribute to a significant elevation of urinary activity and NAG B excretion in response to inflammatory conditions.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000118 Acetylglucosaminidase A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue. N-Acetyl-beta-D-glucosaminidase,Chitobiase,N,N-Diacetylchitobiase,N-Ac-beta-Glucosaminidase,NAGase,beta-D-Acetamido-2-Deoxyglucosidase,beta-D-N-acetylglucosaminidase,beta-N-Acetylglucosaminidase,N Ac beta Glucosaminidase,N Acetyl beta D glucosaminidase,N,N Diacetylchitobiase,beta D Acetamido 2 Deoxyglucosidase,beta D N acetylglucosaminidase,beta N Acetylglucosaminidase
D015054 Zymosan Zymosan A

Related Publications

R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
September 1986, Clinica chimica acta; international journal of clinical chemistry,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
May 1987, Clinica chimica acta; international journal of clinical chemistry,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
June 1983, Clinica chimica acta; international journal of clinical chemistry,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
January 1989, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
April 1995, Occupational and environmental medicine,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
March 1987, Hinyokika kiyo. Acta urologica Japonica,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
November 1998, Clinica chimica acta; international journal of clinical chemistry,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
January 1989, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
March 1988, Pathologie-biologie,
R Bourbouze, and F Raffi, and G Dameron, and H Hali-Miraftab, and F Loko, and J L Vilde
December 1985, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!